Format

Send to

Choose Destination
Cell Cycle. 2016 Dec 16;15(24):3333-3334. doi: 10.1080/15384101.2016.1229019. Epub 2016 Sep 9.

Targeting transcriptional co-activators in advanced prostate cancer.

Author information

1
a Department of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.
2
b Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.
3
c Institute of Oncology Research, Oncology Institute of Southern Switzerland , Bellinzona , Switzerland.
4
d Faculty of Biology and Medicine, Center Hospitalier, Universitaire Vaudois, University of Lausanne , Lausanne , Switzerland.

KEYWORDS:

Bromodomain; LXXLL motif; TRIM24; prostate cancer progression; targeting androgen receptor-mediated transcription

PMID:
27610751
PMCID:
PMC5224444
DOI:
10.1080/15384101.2016.1229019
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center